World

Questions Raised About AstraZeneca-Oxford Vaccine Data

[ad_1] Concern is mounting about the way Oxford University and AstraZeneca have handled early reading of trials for their coronavirus vaccine, which much of the developing world can rely on to emerge from the pandemic. The results were hailed as a success for showing an average efficacy of 70 percent, …

Read More »